A nocturnal temperature controlled laminar flow device (TLA) maintains good control of severe allergic asthma (SAA) after withdrawal of Omalizumab therapy

Chun-Hua Wang, Chun-Yu Lo, Han-Pin Kuo

Research output: Contribution to journalJournal Article peer-review

Original languageAmerican English
JournalEuropean Respiratory Journal
Volume52
DOIs
StatePublished - 2018

Cite this